Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Executive Q&A - Early Drug Development
In this Q&A, we explore early-stage pharmaceutical drug development trends, key scientific and technical challenges, and the role emerging technologies play in enhancing efficiency and quality during early pharmaceutical development. read more
An Interview With Christoph van Eickels, Dr. Deepak Venkanna, and Holly Olmstead
Executive Q&A topic: Regulatory Requirements for Upstream Bioprocess Solutions read more
An Interview With Andreas Eschbach
How has AI acceptance evolved in the pharmaceutical sector, and what strategies have been most effective in overcoming resistance to AI adoption? read more
Horizon Lines: A Quarterly Review of NDAs – July-September 2025
This quarterly review on New Drug Applications contains data for applications approved during the third quarter of 2025, which includes New Molecular Entities (NMEs) and new biologics. A total of 48 applications were approved by the FDA during these three months. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Syngene to Collaborate with Johns Hopkins University to Advance Early-Stage Drug Discovery
Wednesday, February 11, 2026
Syngene International announced a strategic collaboration with Johns Hopkins University, MD, U.S., to advance early stage drug discovery programs and ... read more
Kincell Bio Partners with RegCell to Advance Treg Cell Therapies into Clinical Trials for Autoimmune Diseases
Wednesday, February 11, 2026
Kincell Bio announced a new collaboration with RegCell. Under the partnership, Kincell Bio will provide comprehensive CMC development and GMP ... read more
Rentschler Biopharma appoints Dr. Veit Bergendahl as COO and Nember of the Executive Board
Wednesday, February 11, 2026
Rentschler Biopharma SE announced the appointment of Veit Bergendahl, PhD, as Chief Operating Officer (COO) and member of the Executive Board. He ... read more
IQVIA and Duke Clinical Research Institute Collaborate to Advance Clinical Research in Obesity and Related Conditions
Wednesday, February 11, 2026
IQVIA and the Duke Clinical Research Institute (DCRI) announced a collaboration to enhance the conduct of clinical research in obesity and related ... read more
MMS Appoints Former FDA Staffer as Senior Medical Director, Safety Risk Management
Tuesday, February 10, 2026
MMS, a global, data-focused clinical research organization (CRO), announced that Somya Dunn, MD, has joined the company as Senior Medical Director, ... read more